Troglitazone, an insulin sensitizer, increases forearm blood flow in humans

American Journal of Hypertension

Volumn 11, Issue 9, 1998, Pages 1134-1137

  Fujishima, Shinichiro ^a   Ohya, Yusuke ^a   Nakamura, Yoshito ^a   Onaka, Uran ^a   Isao, Abe ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Antidiabetic agent; Peripheral blood flow; Thiazolidinedione

Indexed keywords

INSULIN; NITRATE; TROGLITAZONE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION;

ADULT; CHROMANS; FOREARM; HUMANS; HYPOGLYCEMIC AGENTS; MALE; REGIONAL BLOOD FLOW; THIAZOLES; THIAZOLIDINEDIONES; VASODILATOR AGENTS;

EID: 0032167679     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00130-7     Document Type: Article

References (15)

1. 1. Nolan JJ, Ludvik B, Beerdsen P, et al: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994;331: 1188-1193.
2. 2. Iwamoto Y, Kosaka K, Kuzuya T, et al: Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy. Diabetes Care 1996;19:151-156.
3. 3. Ogihara T, Rakugi H, Ikegami H, et al: Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. Am J Hypertens 1995;8: 316-320.
4. 4. Sowers JR: Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997;29:691-699.
5. 5. Buchanan TA, Meehan WP, Jeng YY, et al: Blood pressure lowering by pioglitazone: evidence for a direct vascular effect. J Clin Invest 1995;96:354-360.
6. 6. Zhang F, Sowers JR, Ram JL, et al: Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension 1994;24:170-175.
7. 2+ currents and not endothelial nitric oxide production. Diabetes 1997;46:659-664.
8. 8. Nakamura Y, Ohya Y, Onaka U, et al: Inhibitory action of insulin-sensitizing agents on calcium channels in smooth muscle cells from resistance arteries of guineapig. Br J Pharmacol 1998;123:675-682.
9. 9. Fujishima S, Imaizumi T, Abe I, et al: Effects of intra-arterial infusion of insulin on forearm vasore-activity in hypertensive humans. Hypertens Res 1995;18:227-233.
10. 15N]nitrate in biological fluids. Anal Biochem 1982;126:131-138.
11. 11. Shibata H, Arai S, Kobayashi M, et al: Phase I study of a new hypoglycemic agent CS-045 in healthy volunteers-safety and pharmacokinetics in single administration (Article in Japanese; abstract in English). Rinsho Iyaku 1993;9:1519-1537.
12. 12. Kotchen TA, Zhang HY, Reddy S, et al: Effect of pioglitazone on vascular reactivity in vivo and in vitro. Am J Physiol 1996;270:R660-R666.
13. 13. Dominiczak AF, Bohr DF: Nitric oxide and its putative role in hypertension. Hypertension 1995;25:1202-1211.
14. 14. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989;321:868-873.
15. 15. Sheu WH, Swislocki AL, Hoffman B, et al: Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension. Am J Hypertens 1991;4:199-205.